Filing Details

Accession Number:
0001683168-24-002047
Form Type:
5
Zero Holdings:
No
Publication Time:
2024-04-01 21:36:09
Reporting Period:
2023-12-31
Accepted Time:
2024-04-01 21:36:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX () 5
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486558 E. Mark Pearson 5960 Berkshire Ln
Floor 6
Dallas TX 75225
No No No Yes
1745878 Altamont Pharmaceutical Holdings, Llc 5960 Berkshire Ln
Floor 6
Dallas TX 75225
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-11 400,000 $0.23 4,880,000 No 4 S Indirect See fn.
Common Stock Disposition 2024-03-22 20,000 $0.23 4,860,000 No 4 S Indirect See fn.
Common Stock Disposition 2024-03-25 780,000 $0.22 4,080,000 No 4 S Indirect See fn.
Common Stock Disposition 2024-03-26 2,000,000 $0.20 2,080,000 No 4 S Indirect See fn.
Common Stock Disposition 2024-03-27 306,924 $0.17 1,773,076 No 4 S Indirect See fn.
Common Stock Disposition 2024-03-28 693,076 $0.15 1,080,000 No 5 S Indirect See fn.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See fn.
No 4 S Indirect See fn.
No 4 S Indirect See fn.
No 4 S Indirect See fn.
No 4 S Indirect See fn.
No 5 S Indirect See fn.
Footnotes
  1. Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC ("Altamont"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares.